This website is intended for use by residents of Sweden only
About Isofol
Isofol Medical AB (publ) is a biotech company that was founded in 2008 and is developing a new drug candidate for the treatment of advanced colorectal cancer. Colorectal cancer (CRC) is the third most common form of cancer worldwide and the need for more effective drugs to treat this disease is very high.
MEET OUR NEW
Chairman of the Board
Jan Törnell
Upcoming Events
- November 29, 2022 - November 29, 2022
Interim Report Q3 2022 - February 23, 2023 - February 23, 2023
Year-end Report 2022
